Original BioMedicals Co., Ltd. (TPEX: 6483)
Health Care · Biotechnology · TW
NT$11.90
+3.93% today · +6.7% 1Y
Original BioMedicals Co., Ltd. (TPEX: 6483) operates in the Biotechnology industry within the Health Care sector. The company is valued at $24.50M and employs 25 people.
Over the last twelve months the share price has gained 6.7%, trading between 9.12 and 20.00.
Tweenvest scores Original BioMedicals Co., Ltd. across four factors: quality 38/100, value 13/100. Its strongest factor is quality.
6483 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.50M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -1.53
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- NT$20.00
- 52-week low
- NT$9.12
- Avg volume (3M)
- —
- Shares outstanding
- 66.81M
- Employees
- 25
- Next earnings
- —
About Original BioMedicals Co., Ltd.
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
- ISIN
- TW0006483001
- Founded
- 2011
- Listed since
- Mar 27, 2024
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Genvor IncorporatedOTCPK: GNVR | $24.85M | $0.68 | -24.17% |
| Thiogenesis Therapeutics, Corp.TSXV: TTI | $24.74M | CA$0.50 | -5.66% |
| Seres Therapeutics, Inc.NasdaqGS: MCRB | $24.71M | $2.46 | -9.23% |
| Lukas Biomedical Inc.TPEX: 6814 | $24.52M | NT$19.00 | +2.70% |
| Ribomic Inc.TSE: 4591 | $24.36M | ¥68.00 | -4.23% |
| Polyrizon Ltd.NasdaqCM: PLRZ | $24.29M | $10.00 | +11.26% |
| Shuttle Pharmaceuticals Holdings, Inc.NasdaqCM: SHPH | $24.20M | $5.08 | -4.69% |
| Eutilex.Co.,LtdKOSDAQ: A263050 | $24.14M | ₩— | — |
Figures last refreshed Oct 18, 2026.